Skip to main content
. 2021 Nov 2;9:e12303. doi: 10.7717/peerj.12303

Figure 3. Effect of daunorubicin on cell viability in leukemic cell lines.

Figure 3

(A) NB4 and (B) MOLT-4 leukemic cells were treated with various concentrations of daunorubicin for 24 and 48 h. Cell viability was determined by MTS assay. *p < 0.05 was considered to be a statistically significant difference from the control.